指南与共识癫痫

功能性发作管理实践指南执行摘要:AAN指南小组委员会报告

Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee.
指南 / 共识 · Neurology · 2025-12-10

本指南由美国神经病学学会(AAN)指南小组委员会按美国国家医学院合规流程制定,通过系统综述整合12项II-III类研究证据与专家临床经验,提出功能性发作管理的循证推荐。指南强调从患者和目击者获取病史与发作学信息、可行时记录视频脑电图、筛查共病精神障碍与癫痫,并规范心理干预转介、药物使用与诊断告知。

要点

  • 评估发作性事件时应从患者和目击者获取病史与发作学信息(含手机视频),可行时获取所有典型发作的视频脑电图。
  • 应筛查功能性发作患者共病精神障碍与共病癫痫,并提供具体诊断标签、理由及共同决策。
  • 无共病癫痫或其他适应证时不应处方苯二氮䓬类或抗癫痫发作药物,并应逐步减停抗癫痫发作药物。

核心结论

  • 心理干预可能有效提高功能性发作无发作的可能性、减少发作频率、减轻焦虑并改善健康相关生活质量与心理社会功能。
  • 临床应遵循普遍照护标准,包括尊重患者、避免不必要伤害和避免污名化行为。
  • 应为功能性发作患者提供具体诊断标签和诊断理由,并开展治疗计划的共同决策与连续性照护。

研究设计与样本

  • 指南遵循美国国家医学院合规流程制定;多学科小组开展系统综述并将结果与作者临床经验整合形成推荐。
  • 系统综述检索从最早发表文章至2025年2月25日的证据,纳入12项II-III类研究。

主要发现

  • 心理干预可能有效提高功能性发作无发作的可能性、减少发作频率、减轻焦虑并改善健康相关生活质量与心理社会功能。
  • 指南还指出现有证据的空白并概述未来研究可能具有临床影响的方向。

关键数值与推荐

  • 评估发作性事件时,临床医生应寻求患者和目击者的病史与发作学信息(包括智能手机视频),可行时获取所有典型发作性事件的视频脑电图。
  • 应评估功能性发作患者是否共病精神障碍和共病癫痫。
  • 有心理干预指征时,应告知患者潜在获益与风险,并将有兴趣且合适的患者转介至心理干预。
  • 应将家庭成员、照护者或其他社会支持网络成员纳入功能性发作患者的心理治疗。
  • 无共病癫痫或其他适应证时不应处方苯二氮䓬类或抗癫痫发作药物,并应告知用于功能性发作的潜在风险与获益证据缺乏;对无其他适应证的抗癫痫发作药物应逐步减停。

临床怎么用

  • 将心理干预作为功能性发作的可能有效治疗选择,并在共同决策基础上转介合适的患者。
  • 向患者提供明确诊断标签和理由,筛查共病精神障碍与共病癫痫,并保持连续性照护。
  • 避免对无共病癫痫或其他适应证的功能性发作患者处方苯二氮䓬类或抗癫痫发作药物,并逐步减停无其他适应证的抗癫痫发作药物。
  • 在心理治疗中纳入家庭、照护者或其他社会支持网络成员。
  • 临床医生应遵守普遍照护标准,尊重患者、避免不必要伤害和避免污名化行为。

局限性

  • 系统综述仅纳入12项II-III类研究,证据等级有限。
  • 指南指出可用证据存在空白,并概述未来研究方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This guideline provides evidence-based recommendations for clinicians, patients, and other stakeholders on the management of functional seizures. Following a National Academy of Medicine-compliant process, a multidisciplinary panel conducted a systematic review and integrated the findings with the authors' clinical experience to develop recommendations. A systematic review of the available evidence from first published articles to February 25, 2025, identified 12 Class II-III studies. The review found that psychological interventions are possibly effective in increasing the likelihood of achieving freedom from functional seizures, decreasing the frequency of functional seizures, decreasing anxiety, and improving health-related quality of life and psychosocial functioning for individuals with functional seizures. Key recommendations state that, when evaluating patients with seizure-like episodes, clinicians should seek historical and semiological information (including smartphone videos) from both patients and witnesses and may obtain video-EEG of all typical seizure-like episodes where feasible. Clinicians should evaluate patients diagnosed with functional seizures for co-occurring psychiatric disorders and co-occurring epilepsy. Clinicians should adhere to universal standards of care for patients, including speaking respectfully, refraining from unnecessary harm, and avoiding stigmatizing behavior. Clinicians should provide a specific diagnostic label and rationale for the diagnosis, should engage in shared decision making regarding the treatment plan, and should provide continuity of care to individuals diagnosed with functional seizures. When psychological interventions for functional seizures are indicated, clinicians should counsel patients regarding the potential benefits and risks of these interventions and should refer interested and appropriate patients to these interventions for the treatment of functional seizures. Clinicians should involve family, caregivers, or others in the social support network in the psychological treatment of individuals with functional seizures. Clinicians should not prescribe benzodiazepines or antiseizure medications for patients with functional seizures without co-occurring epilepsy or another indication for these medications and should counsel patients regarding the potential risks and lack of evidence of benefit for using these medications for functional seizures. Clinicians should taper off antiseizure medications for patients with functional seizures and without another indication for these medications. The guideline also identifies gaps in the available evidence and outlines potentially clinically impactful avenues for future research.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tolchin B, Goldstein LH, Reuber M, et al. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2025. PMID: 41370742. doi:10.1212/WNL.0000000000214466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。